ES
WIPO international registration designating the UK WO0000001944941
TELUM THERAPEUTICS
Official representation
Trade mark image
Stored locally from an official UKIPO, EUIPO or WIPO source and matched by the exact registration number.


WIPO international registration designating the UK WO0000001944941
Official representation
Stored locally from an official UKIPO, EUIPO or WIPO source and matched by the exact registration number.

Official source data
Nice classification
Wording supplied in the official WIPO ROMARIN update WIPO-20261012.
Diagnostic products for scientific use; reagents for medical research; Reagents for medical research in the field of infectious diseases and diseases caused by bacteria; diagnostic reagents for scientific use or for research; Enzymes for scientific use; diagnostic kits for scientific use comprising specimen receptacles and reagents for analyzing selected bacteria.
Pharmaceutical products for infectious disease treatment; pharmaceutical products for treatment of diseases caused by bacteria; Antibacterial pharmaceutical products; antibiotics; Biopharmaceuticals for infectious disease treatment; immunotherapeutic agents for bacterial infections; Enzyme preparations for medical use; enzymes for medical use; Enzymes and enzyme preparations for diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria; tests, biomarkers and reagents for diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria.
Biomedical research services; scientific research for medical purposes in the field of infectious diseases and diseases caused by bacteria; Research and development of pharmaceutical products, antibiotics, tests, biomarkers and reagents for diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria; research and development of immunotherapeutic agents for bacterial infections; Research and development of enzymes, enzyme preparations and synthetic proteins for diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria; clinical trials for pharmaceutical products, antibiotics, tests, biomarkers and reagents for diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria; Software as a Service [SaaS]; Platform as a Service [PaaS]; Artificial Intelligence as a Service [AIaaS].